Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-01-02 @ 1:35 PM
Study NCT ID:
NCT06304857
Status:
RECRUITING
Last Update Posted:
2024-12-04
First Post:
2023-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Sponsor:
4th Military Clinical Hospital with Polyclinic, Poland
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022/ABM/01/00039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None